Biopharma professional on laptop browsing Pink Sheet for global policy and regulatory insights.

A collection of Pink Sheet articles covering evolving EU regulations on clinical trial disclosure and transparency. Pink Sheet provides global policy and regulatory insights for biopharma decision-makers.

As a regulator it is imperative that we are able to take action when absolutely necessary to safeguard patients.
UK MHRA

Related resources

Infographic preview of The 9 Hidden Costs of Clinical Trial Disclosure.
OCT 06, 2023
Infographic
薬事規制関連支援サービス

9 Hidden Costs of Trial Disclosure

From system implementation to protocol registration and process assessment, hidden costs lurk at every step of the clinical trial disclosure process.

Digital representation of the globe.
MAR 01, 2023
Whitepaper
薬事規制関連支援サービス

Global Clinical Trial Disclosure: What Noncompliance Penalties Are in Place, & How They Are Enforced

Industry groups and transparency advocates call for enforcing clinical trial disclosure noncompliance penalties. But are regulatory agencies doing so?

Trial Summaries-Improving Patient-Centric Communications resource-card-thumbnail
JUL 01, 2023
Whitepaper
薬事規制関連支援サービス

Trial Summaries Improving Patient-Centric Communications

The Pharma R&D Annual Review 2023 Supplement looks at new active substances (NASs), drugs launched onto the market for the first time, during 2022